Glympse to Present Data from First Application of New Liquid Biopsy Diagnostic Platform at AASLD's The Liver Meeting 2021

/PRNewswire/ -- Glympse, a biotechnology company developing revolutionary technology to diagnose and monitor disease, today announced that it will be...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Maggie Beller ,Matthew Navarro ,Prnewswire Glympse ,Arunj Sanyal ,Glympse Bio ,Caroline Loew ,Virginia Commonwealth University ,Russo Partners ,American Association ,Liver Disease ,Liver Meeting ,Tram Tran ,Chief Medical Officer ,Chief Executive Officer ,Accurate Diagnosis ,Novel Protease Based Liquid ,Late Breaking Abstracts ,